Around 46million people globally are suffering from diabetes currently. Their life could be more easier with better diabetes treatment. Researchers from the University of Copenhagen and biotech firm Gubra have found a solution of insulin molecule that will ensure that the patients get just the right amount of insulin, in future.
Now the insulin in the market cannot determine if the patient of Type 1 diabetes needs small or large amounts of insulin. Insulin leads to lowering in blood sugar level.
“That is why we have developed the first step towards a kind of insulin that can self-adjust according to a patient’s blood sugar level. This has tremendous potential to improve the lives of people with type 1 diabetes vastly,” explains Professor Knud J. Jensen, of the University of Copenhagen’s Department of Chemistry, one of the researchers behind a new study on this new insulin.
Effects On Rats:
The researchers did experimentation in rats which turned out effective for them.
They developed a type of insulin with a built-in molecular binding mechanism that senses how much blood glucose is present in the body.
If the amount rises, the molecule becomes more active and releases more insulin. And when it drops, less is released.
“The molecule constantly releases a small amount of insulin but varies according to need. It will give type 1 diabetes patients a safer and easier treatment. Today, a person with type 1 diabetes must inject themselves with insulin many times throughout the day and frequently monitor their blood sugar level by pricking their finger with a blood glucose meter. This here, allows a person to inject the new insulin molecule less often over the course of a day and thereby think about it less,” says Knud J. Jensen.
This new molecular insulin is a better option, but it will be a while until used commercially.
“We’ve tested the insulin molecule on rats, and it has proven itself effective. The next step is to develop the molecule so that it works more rapidly and accurately. And finally, to test it in humans — a process that can take many years. But it is certainly worth pinning one’s hopes on,” explains Professor Jensen
This News has been taken from sciencedaily.com. The language may differ from the original language, find the original source here.
Source:
University of Copenhagen. “Better diabetes treatment: New insulin molecule can self-regulate blood sugar.” ScienceDaily. ScienceDaily, 3 December 2020. <www.sciencedaily.com/releases/2020/12/201203122255.htm>.
